clopidogrel and rivaroxaban

clopidogrel has been researched along with rivaroxaban in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	38 (57.58)	24.3611
2020's	28 (42.42)	2.80

Authors

Authors	Studies
Bai, N; Chen, C; Chen, P; Fu, H; Guo, Y; Lam, YPY; Li, M; Li, W; Malhotra, S; O'Connor, PB; Wu, Q; Zhang, D	1
Mustonen, P; Puurunen, M	1
Halperin, JL; Varughese, CJ	1
Bhatt, DL; Kar, S	1
Badimon, JJ; Becker, EM; Bütehorn, U; Kast, R; Klipp, A; Laux, V; Lücker, C; Perzborn, E	1
Stiefelhagen, P	1
He, B; Kun, L; Liu, X; Wu, B	1
Dugdale, M; Fabian, TC; Gordon, JL; Lee, MD	1
Becker, RC; Breithardt, G; Califf, RM; Fox, KA; Goodman, SG; Hacke, W; Halperin, JL; Hankey, GJ; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Singer, DE; Stevens, SR; White, HD	1
Gupta, K; Singh, D; Vacek, JL	1
Gnall, EM; Ice, DS; Kowey, PR; Shapiro, TA	1
Gislason, G; Sørensen, R	1
Bultas, J	1
Calıskan, A; Demirtas, S; Guclu, O; Kaplan, I; Karahan, O; Tezcan, O; Yavuz, C; Yazıcı, S	1
Bode, C; Cohen, M; Fox, K; Gibson, CM; Halperin, J; Husted, S; Lip, GY; Mehran, R; Peterson, E; van Eickels, M; Verheugt, F; Wildgoose, P	1
Heitmeier, S; Laux, V; Perzborn, E	1
Gao, F; Liu, XL; Shen, H; Wang, ZJ; Yang, SW; Zhou, YJ	1
Hwang, JC; Jun, JH	1
Bernlochner, I; Bradaric, C; Dirschinger, RJ; Dommasch, M; Ibrahim, T; Jaitner, J; Langwieser, N; Laugwitz, KL; Wustrow, I	1
Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP	1
Cabrera-Fuentes, HA; Cherepanov, V; Kim, MH; Serebruany, VL	1
Bode, C; Diehl, P; Meyer, M; Moser, M; Olivier, CB; Weber, S; Weik, P; Zhou, Q	1
Bode, C; Gibson, CM; James, S; Mundl, H; Ohman, EM; Plotnikov, A; Povsic, TJ; Roe, MT; Steg, PG; Welsh, R	1
Adler, DG; Jex, KT; Nicaud, MJ; Raines, DL	1
Bordignon, S; Chun, JK; Dugo, D; Fürnkranz, A; Konstantinou, A; Perrotta, L; Schmidt, B	1
Musgrave, KM; Powell, J	1
Baber, U; Dangas, GD; Giustino, G; Guimarães, AH; Hemmrich, M; Mehran, R; Thomitzek, K; Tijssen, J; Valgimigli, M; van Es, GA; Volkl, AA; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Zazula, A	1
Ardissino, D; Bahit, MC; Bode, C; Bueno, H; Claeys, MJ; Cornel, JH; Gibson, CM; Goto, S; Güray, Ü; Husted, S; James, SK; Kiss, RG; Montalescot, G; Mundl, H; Nicolau, JC; Ohman, EM; Park, DW; Plotnikov, A; Povsic, TJ; Rockhold, F; Roe, MT; Steg, PG; Strony, J; Sun, X; Tendera, M; Welsh, RC; White, J	1
Barmparas, G; Bosarge, P; Brown, CV; Bukur, M; Carrick, MM; Catalano, RD; Coimbra, R; Holly-Nicolas, J; Inaba, K; Kaminski, S; Klein, AL; Kobayashi, L; Kopelman, T; Ley, EJ; Martinez, EM; Moore, FO; Murry, J; Nirula, R; Paul, D; Quick, J; Rivera, O; Schreiber, M	1
Gibler, WB	1
Espinola-Klein, C	1
Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR	1
Hoppe, UC; Jung, C; Lauten, A; Lichtenauer, M; Navarese, EP; Wernly, B	1
Filis, K; Kakkos, SK; Karaolanis, G; Moris, D; Sigala, F; Tsilimigras, DI	1
Alexiou, E; Geroulakos, G; Lazaris, AM; Poulou, A	1
Aboyans, V; Anand, SS; Bauersachs, R; Bosch, J; Debus, ES; Eikelboom, JW; Mazzolai, L; Nehler, M; Nikol, S; Pastori, D; Patel, MR; Ricco, JB; Tanguay, JF; Verhamme, P; Violi, F	1
Bhupathi, V; Shanker, A	1
Bode, C; Cornel, JH; Gibson, CM; James, S; Montalescot, G; Mundl, H; Nicolau, JC; Ohman, EM; Plotnikov, AN; Povsic, TJ; Rockhold, FW; Roe, MT; Steg, PG; Welsh, RC; White, J	1
Baldus, S; Dangas, GD; De Backer, O; Gilard, M; Giustino, G; Guimarães, AHC; Gullestad, L; Herrmann, HC; Kini, A; Mack, M; Makkar, RR; Mehran, R; Möllmann, H; Moreno, R; Schäfer, U; Seeger, J; Søndergaard, L; Tchétché, D; Thomitzek, K; Tijssen, JGP; Valgimigli, M; van Amsterdam, RGM; Volkl, AA; von Lewinski, D; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Wöhrle, J; Zazula, A	1
Abdel-Wahab, M; Arnold, M; Balan, P; Blanke, P; Dangas, GD; De Backer, O; Guimarães, AHC; Jeger, RV; Jilaihawi, H; Kim, WK; Kini, AS; Kofoed, KF; Leipsic, JA; Makkar, R; Mathiassen, ON; Mehran, R; Nørgaard, BL; Søndergaard, L; Terkelsen, CJ; Van Mieghem, N; Veien, KT; Windecker, S	1
Liao, YWB; Wang, TKM	1
Gorog, DA; Gue, YX; Kanji, R; Srinivasan, M; Wellsted, DM; Wyatt, S	1
Masarova, L; Novak, J; Ondrasek, J; Panovsky, R; Pesl, M; Semenka, J; Simarova, E	1
Juvet, F; Kelly, D; Moore, G	1
Chen, T; Li, J; Li, X; Lv, Q; Wu, H; Xu, Q	1
Darius, H	1
Bernlochner, I; Goedel, A; Gosetti, R; Kastrati, A; Laugwitz, KL; Sarafoff, N	1
Kwon, O; Masic, D; Rech, MA	1
Anand, SS; Bauersachs, R; Berkowitz, SD; Bonaca, MP; Brackin, T; Brasil, D; Capell, WH; Debus, ES; Haskell, L; Hess, CN; Hiatt, WR; Jaeger, N; Madaric, J; Muehlhofer, E; Nehler, MR; Pap, AF; Patel, MR; Sillesen, H; Szalay, D	1
Haruta, H; Hirayama, A; Hiro, T; Kitano, D; Kurosawa, T; Li, Y; Matsumoto, T; Migita, S; Mitsumata, M; Okumura, Y; Sudo, M; Takahashi, R; Takayama, T; Taniguchi, Y	1
Akao, M; Ako, J; Hagiwara, N; Hirayama, A; Kaikita, K; Kimura, K; Matoba, T; Matsui, K; Miyauchi, K; Nakamura, M; Ogawa, H; Yasuda, S	1
Georges, CJ; Li, RH; Lo, ST; Stern, JA; Walker, AL	1
Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L	1
Ambler, GK; Behrendt, CA; Nordanstig, J; Twine, CP	1
Angiolillo, DJ; Bass, TA; Been, L; Franchi, F; Galli, M; Geisler, T; Jaoude, PA; Jennings, LK; Jia, S; Lee, CH; Maaliki, N; Pineda, AM; Rivas, A; Rollini, F; Soffer, D; Suryadevara, S; Zenni, MM; Zhou, X	1
Brooks, MB; Goggs, R; Lynch, AM; Tracy, AL	1
Anand, SS; Bauersachs, RM; Beckman, JA; Berkowitz, SD; Bonaca, MP; Bura-Rivière, A; Capell, WH; Debus, ES; Haskell, LP; Henkin, S; Hess, CN; Hsia, J; Lawall, H; Muehlhofer, E; Nehler, MR; Patel, MR; Piazza, G; Roztocil, K; Szarek, M	1
de Borst, GJ; Hannink, G; Kramers, K; Maas, DPMSM; Mees, BME; Reijnen, MMPJ; Riksen, NP; Ten Cate, H; van der Vijver-Coppen, RJ; Warlé, MC; Willems, LH; Zeebregts, CJ	1
Kanny, O; Khan, H; Qadura, M; Syed, MH	1
Chen, X; Jiang, L; Liu, C; Su, J; Zheng, N; Zhong, J	1
Aboyans, V; Angiolillo, D; Atar, D; Capodanno, D; Fox, KAA; Halvorsen, S; James, S; Jüni, P; Kunadian, V; Landi, A; Leonardi, S; Mehran, R; Montalescot, G; Navarese, EP; Niebauer, J; Oliva, A; Piccolo, R; Price, S; Storey, RF; Valgimigli, M; Völler, H; Vranckx, P; Windecker, S	1
Gong, Y; Li, J; Wang, X; Wang, Y; Zhou, T	1
Ito, Y; Kimata, M; Koseki, T; Sekido, K; Tanaka, J; Yamada, S	1
Farag, A; Hamabe, L; Mandour, AS; Matsumoto, K; Tanaka, R; Uemura, A; Yoshida, T	1
Cai, Y; Chen, Z; He, Y; Li, C; Zhang, J	1
Liu, C; Ma, L	1

Reviews

23 review(s) available for clopidogrel and rivaroxaban

Article	Year
[New antithrombotic drugs]. Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:7 Topics: Adenosine; Anticoagulants; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin	2012
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2012, Volume: 35, Issue:1 Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin	2012
Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents. Coronary artery disease, 2012, Volume: 23, Issue:6 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Warfarin	2012
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. The journal of trauma and acute care surgery, 2013, Volume: 75, Issue:3 Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondaparinux; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Platelet Transfusion; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Ticlopidine; Warfarin	2013
Anticoagulation and antiplatelet therapy in acute coronary syndromes. Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin	2014
Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome. The American journal of cardiology, 2014, Mar-01, Volume: 113, Issue:5 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Morpholines; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Thrombosis; Ticlopidine	2014
[Anticoagulant therapy in secondary prevention of coronary events]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:12 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Ticlopidine; Warfarin	2014
Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adenosine; Animals; Anticarcinogenic Agents; Aspirin; Blood Platelets; Carcinogenicity Tests; Clopidogrel; Colonic Neoplasms; Drug Therapy, Combination; Female; Humans; Lactones; Male; Mice; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Randomized Controlled Trials as Topic; Rivaroxaban; Sex Factors; Species Specificity; Ticagrelor; Ticlopidine; Time Factors	2015
A systematic review of anti-thrombotic therapy in epistaxis. Rhinology, 2016, 12-01, Volume: 54, Issue:4 Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Clopidogrel; Dabigatran; Disease Management; Epistaxis; Humans; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Ticlopidine; Tranexamic Acid; Warfarin	2016
Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease. Critical pathways in cardiology, 2018, Volume: 17, Issue:2 Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; DNA; Drug Therapy, Combination; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Histones; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Thrombosis; Warfarin	2018
[Anti-Thrombotic Treatment of Patients with Peripheral Artery Disease (PAD)]. Deutsche medizinische Wochenschrift (1946), 2018, Volume: 143, Issue:15 Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Germany; Guideline Adherence; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Postoperative Care; Rivaroxaban; Secondary Prevention; Ticlopidine; Veins	2018
Triple therapy: worth the risk? Minerva medica, 2018, Volume: 109, Issue:5 Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Humans; Mortality; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Rivaroxaban; Stents; Stroke; Thrombophilia; Ticlopidine	2018
Rivaroxaban versus Clopidogrel for Peripheral Artery Disease: A Clinico-Economic Approach of the COMPASS Trial. Current pharmaceutical design, 2018, Volume: 24, Issue:38 Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Peripheral Arterial Disease; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome	2018
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy. Thrombosis and haemostasis, 2019, Volume: 119, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atherosclerosis; Cardiology; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Risk; Rivaroxaban	2019
Secondary Prevention with Antithrombotic Therapies in Stable Ischemic Heart Disease Patients: a Review. Current cardiology reports, 2019, 05-18, Volume: 21, Issue:7 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Rivaroxaban; Secondary Prevention	2019
Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials. Coronary artery disease, 2020, Volume: 31, Issue:3 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Ticagrelor; Warfarin	2020
Antithrombotic Therapy of a Young Adult with Giant Left Main Coronary Artery Aneurysm. International heart journal, 2020, May-30, Volume: 61, Issue:3 Topics: Clopidogrel; Coronary Aneurysm; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Young Adult	2020
Network Meta-analysis of the Benefit of Aspirin with Rivaroxaban vs. Clopidogrel for Patients with Stable Symptomatic Lower Extremity Arterial Disease. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2021, Volume: 62, Issue:4 Topics: Aged; Aspirin; Clopidogrel; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Lower Extremity; Male; Middle Aged; Network Meta-Analysis; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome	2021
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis. Drugs, 2022, Volume: 82, Issue:12 Topics: Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Network Meta-Analysis; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Ticagrelor; Vitamin K	2022
Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy. International journal of molecular sciences, 2022, Sep-26, Volume: 23, Issue:19 Topics: Anticoagulants; Aspirin; Clopidogrel; Factor X; Humans; Platelet Aggregation Inhibitors; Point-of-Care Testing; Rivaroxaban; Ticagrelor; Vascular Diseases	2022
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023, Volume: 23, Issue:3 Topics: Aspirin; Atherosclerosis; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Stroke; Myocardial Infarction; Network Meta-Analysis; Platelet Aggregation Inhibitors; Regression Analysis; Rivaroxaban; Stroke; Ticagrelor	2023
Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis. Cardiovascular therapeutics, 2023, Volume: 2023 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Fibrinolytic Agents; Humans; Ischemic Stroke; Network Meta-Analysis; Platelet Aggregation Inhibitors; Rivaroxaban; Ticagrelor	2023
Comparison efficacy and safety of different antiplatelet or anticoagulation drugs in chronic coronary syndromes patients: A Bayesian network meta-analysis. Medicine, 2023, Dec-01, Volume: 102, Issue:48 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Bayes Theorem; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Network Meta-Analysis; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rivaroxaban; Ticagrelor; Treatment Outcome	2023

Trials

16 trial(s) available for clopidogrel and rivaroxaban

Article	Year
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. European heart journal, 2014, Volume: 35, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Embolism; Female; Humans; Kaplan-Meier Estimate; Male; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin	2014
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention American heart journal, 2015, Volume: 169, Issue:4 Topics: Administration, Oral; Aged; Atrial Fibrillation; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Rivaroxaban; Thiophenes; Ticlopidine; Treatment Outcome; Vitamin K	2015
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention. Contemporary clinical trials, 2015, Volume: 43 Topics: Adenosine; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Percutaneous Coronary Intervention; Research Design; Rivaroxaban; Ticagrelor; Ticlopidine; Warfarin	2015
Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction. Phlebology, 2016, Volume: 31, Issue:6 Topics: Adolescent; Adult; Clopidogrel; Factor Xa Inhibitors; Female; Femoral Vein; Follow-Up Studies; Humans; Iliac Vein; Male; Middle Aged; Platelet Aggregation Inhibitors; Postthrombotic Syndrome; Rivaroxaban; Stents; Ticlopidine	2016
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. American heart journal, 2016, Volume: 174 Topics: Acute Coronary Syndrome; Adenosine; Adolescent; Adult; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Rivaroxaban; Ticagrelor; Ticlopidine; Treatment Outcome; Young Adult	2016
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study. American heart journal, 2017, Volume: 184 Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Heart Valve Diseases; Humans; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Pulmonary Embolism; Rivaroxaban; Stroke; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement; Venous Thrombosis	2017
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet (London, England), 2017, May-06, Volume: 389, Issue:10081 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Clopidogrel; Coronary Angiography; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rivaroxaban; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Treatment Outcome	2017
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PloS one, 2018, Volume: 13, Issue:8 Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin	2018
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes. JAMA cardiology, 2019, 07-01, Volume: 4, Issue:7 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Rivaroxaban; Ticagrelor	2019
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 2020, 01-09, Volume: 382, Issue:2 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thromboembolism; Transcatheter Aortic Valve Replacement	2020
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 2020, 01-09, Volume: 382, Issue:2 Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Four-Dimensional Computed Tomography; Heart Valve Prosthesis; Hemorrhage; Humans; Intention to Treat Analysis; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thromboembolism; Transcatheter Aortic Valve Replacement	2020
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute Journal of thrombosis and thrombolysis, 2020, Volume: 49, Issue:2 Topics: Acute Coronary Syndrome; Clopidogrel; Dose-Response Relationship, Drug; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Fibrinolysis; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thrombelastography; Thrombosis; Ticagrelor	2020
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety. Circulation, 2020, 12-08, Volume: 142, Issue:23 Topics: Aged; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Humans; Internationality; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Treatment Outcome	2020
Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis. American heart journal, 2021, Volume: 236 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Adjustment; Rivaroxaban; Stroke	2021
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. JAMA network open, 2022, 06-01, Volume: 5, Issue:6 Topics: Aged; Aspirin; Clopidogrel; Cohort Studies; Female; Humans; Lower Extremity; Male; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Venous Thromboembolism	2022
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority ra Trials, 2023, Mar-21, Volume: 24, Issue:1 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Gastrointestinal Diseases; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome	2023

Other Studies

27 other study(ies) available for clopidogrel and rivaroxaban

Article	Year
Discovery of novel, potent, isosteviol-based antithrombotic agents. European journal of medicinal chemistry, 2019, Dec-01, Volume: 183 Topics: Animals; Diterpenes, Kaurane; Drug Discovery; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thrombin; Thrombosis	2019
Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:12 Topics: Animals; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Morpholines; Platelet Aggregation; Rivaroxaban; Stents; Swine; Swine, Miniature; Thiophenes; Thrombosis; Ticlopidine	2012
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)]. MMW Fortschritte der Medizin, 2013, Feb-21, Volume: 155, Issue:3 Topics: Adenosine; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Fibrinolytic Agents; Guideline Adherence; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting. Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; China; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Models, Economic; Morpholines; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Warfarin	2014
Triple antithrombotic therapy: risky but sometimes necessary. Revista espanola de cardiologia (English ed.), 2014, Volume: 67, Issue:3 Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Vitamin K	2014
Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia-reperfusion injury. The Kaohsiung journal of medical sciences, 2015, Volume: 31, Issue:3 Topics: Animals; Anticoagulants; Aryldialkylphosphatase; Aspirin; Cardiotonic Agents; Clopidogrel; Dipeptidases; Drug Evaluation, Preclinical; Enoxaparin; Femoral Artery; Heparin, Low-Molecular-Weight; Hindlimb; Kidney; Male; Malondialdehyde; Morpholines; Myocardium; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Reperfusion Injury; Rivaroxaban; Thiophenes; Ticlopidine	2015
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies. Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:6 Topics: Adenosine; Adult; Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Rivaroxaban; Thrombin; Ticagrelor; Ticlopidine	2015
Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage. JAMA ophthalmology, 2015, Volume: 133, Issue:10 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Clopidogrel; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Ticlopidine; Visual Acuity; Vitreous Hemorrhage; Warfarin	2015
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin	2015
Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors. Journal of thrombosis and thrombolysis, 2016, Volume: 42, Issue:2 Topics: Adenosine Diphosphate; Antithrombins; Arachidonic Acid; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Rivaroxaban; Ticlopidine	2016
Pharmacologic provocation combined with endoscopy in refractory cases of GI bleeding. Gastrointestinal endoscopy, 2017, Volume: 85, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Balloon Enteroscopy; Clopidogrel; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Rivaroxaban; Ticlopidine; Vascular Malformations	2017
Locked Away: Percutaneous Closure of a Malignant Left Atrial Appendage to Constrain an Unresolvable Thrombus. Circulation. Arrhythmia and electrophysiology, 2016, Volume: 9, Issue:8 Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Echocardiography, Transesophageal; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Septal Occluder Device; Thrombosis; Ticlopidine; Vitamin K	2016
Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. The journal of trauma and acute care surgery, 2017, Volume: 82, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dabigatran; Female; Humans; Injury Severity Score; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Wounds, Nonpenetrating	2017
Open Repair of a Ruptured Abdominal Aortic Aneurysm on a Patient Under Rivaroxaban and Clopidogrel. Annals of vascular surgery, 2019, Volume: 58 Topics: Aortic Aneurysm, Abdominal; Aortic Rupture; Aortography; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Clopidogrel; Computed Tomography Angiography; Drug Administration Schedule; Emergencies; Factor Xa Inhibitors; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Rivaroxaban; Treatment Outcome	2019
Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report. BMC cardiovascular disorders, 2020, 02-21, Volume: 20, Issue:1 Topics: Aged; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Heart Atria; Heart Diseases; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve Annuloplasty; Mitral Valve Insufficiency; Platelet Aggregation Inhibitors; Recurrence; Rivaroxaban; Thrombectomy; Thrombosis; Treatment Outcome	2020
Congenital protein C deficiency and thrombosis in a dog. Journal of veterinary internal medicine, 2020, Volume: 34, Issue:3 Topics: Animals; Clopidogrel; Dog Diseases; Dogs; Echocardiography; Factor Xa Inhibitors; Male; Platelet Aggregation Inhibitors; Protein C Deficiency; Rivaroxaban; Thrombosis; Tomography, X-Ray Computed	2020
[Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:14 Topics: Acute Coronary Syndrome; Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Combined Modality Therapy; Cyclophosphamide; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stents; Stroke; Vitamin K	2020
Clopidogrel response in patients receiving the nonvitamin K antagonist oral anticoagulants apixaban and rivaroxaban. Coronary artery disease, 2021, Mar-01, Volume: 32, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Germany; Humans; Male; Percutaneous Coronary Intervention; Platelet Function Tests; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban	2021
Desmopressin with four-factor prothrombin complex concentrate for life-threatening bleeding: A case series. The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Cerebral Hemorrhage, Traumatic; Cerebral Intraventricular Hemorrhage; Clopidogrel; Deamino Arginine Vasopressin; Female; Fractures, Bone; Hematoma; Hematoma, Subdural, Intracranial; Hemostatics; Humans; International Normalized Ratio; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Pelvic Bones; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Subarachnoid Hemorrhage, Traumatic; Thrombosis; Warfarin	2020
Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model. Journal of atherosclerosis and thrombosis, 2022, Jan-01, Volume: 29, Issue:1 Topics: Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Factor Xa Inhibitors; Graft Occlusion, Vascular; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Swine; Tomography, Optical Coherence	2022
Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease. Journal of feline medicine and surgery, 2022, Volume: 24, Issue:4 Topics: Animals; Anticoagulants; Cat Diseases; Cats; Clopidogrel; Humans; Retrospective Studies; Rivaroxaban; Venous Thromboembolism	2022
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban. Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:10 Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin	2021
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. European heart journal. Cardiovascular pharmacotherapy, 2022, Sep-29, Volume: 8, Issue:7 Topics: Aspirin; Clopidogrel; Cyclooxygenase 1; Fibrinolytic Agents; Humans; Peptides; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Thrombin; Rivaroxaban; Thrombin; Thromboplastin; Ticagrelor	2022
Clinical features and posttreatment monitoring of dogs administered rivaroxaban (2018-2020): 19 cases. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2022, Volume: 32, Issue:5 Topics: Animals; Anticoagulants; Clopidogrel; Dog Diseases; Dogs; Factor Xa Inhibitors; Humans; Retrospective Studies; Rivaroxaban; Thrombosis	2022
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneou European heart journal. Cardiovascular pharmacotherapy, 2023, 04-10, Volume: 9, Issue:3 Topics: Aspirin; Cardiology; Clopidogrel; Coronary Artery Disease; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Network Meta-Analysis; Purinergic P2Y Receptor Antagonists; Rivaroxaban; Stroke; Ticagrelor	2023
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2023, Volume: 26 Topics: Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Eye; Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rivaroxaban; Warfarin	2023
Secondary right atrial thrombosis in three dogs: Antithrombotics therapy and echocardiographic follow-up. Veterinary medicine and science, 2023, Volume: 9, Issue:5 Topics: Animals; Atrial Fibrillation; Clopidogrel; Dog Diseases; Dogs; Echocardiography; Fibrinolytic Agents; Follow-Up Studies; Heart Atria; Heart Diseases; Rivaroxaban; Thrombosis	2023